Overview

Comparative Effectiveness of AKYNZEO® and Standard of Care (Including EMEND®) for the Prevention of Nausea and Vomiting (CINV) in Cancer Patients

Status:
Unknown status
Trial end date:
2019-07-31
Target enrollment:
Participant gender:
Summary
This pragmatic trial addresses the clinical gap through the generation of evidence on the comparative effectiveness between AKYNZEO® and Standard of Care (SoC, including EMEND®) in the real-life setting
Phase:
Phase 4
Details
Lead Sponsor:
VIFORFRANCE